newsfilter
← Latest News
GlobeNewswire·

Iambic to participate in Jefferies Global Healthcare Conference

  • Iambic (Nasdaq: IAM) CEO Tom Miller, PhD will attend the Jefferies Global Healthcare Conference in London from November 16-19, 2026.
  • Dr. Miller will participate in a panel on AI in drug discovery on November 18 at 2:00 PM GMT.
  • The 17th annual Jefferies conference is Europe's largest healthcare-focused event featuring leaders in pharma, biotech, & health IT.
  • Iambic utilizes a molecular superintelligence platform integrating proprietary AI with automated chemistry & biology experimentation.
  • The company advanced its lead candidate, IAM1363, to clinical trials in approximately two years.
  • Iambic's leading AI technologies include Enchant & NeuralPLexer for multimodal endpoint prediction.
  • The press release includes standard forward-looking statements regarding the conference, platform potential, & pipeline strategy.
Company
Iambic Therapeutics Inc
Keywords
Nasdaq:IAM, Iambic Therapeutics Inc